Display options
Share it on

Ann Clin Cytol Pathol. 2016;2(4). Epub 2016 Jul 12.

Human Papillomavirus at Multiple Sites Associated with Anal Squamous Intraepithelial Lesions in HIV-Seropositive Individuals.

Annals of clinical cytology and pathology

Eleanore Chuang, Eunjung Lim, Cris Milne, Xuemei Zhu, Melissa Agsalda, Jeffrey Killeen, F DeWolfe Miller, Brenda Y Hernandez, Bruce Shiramizu

Affiliations

  1. Hawaii Center for AIDS, John A. Burns School of Medicine, University of Hawaii, USA; Department of Tropical Medicine, Medical Microbiology & Pharmacology, John A. Burns School of Medicine, University of Hawaii, USA.
  2. Office of Biostatistics and Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii, USA.
  3. Hawaii Center for AIDS, John A. Burns School of Medicine, University of Hawaii, USA.
  4. University of Hawaii Cancer Center, USA.
  5. University of Hawaii Cancer Center, USA; Department of Pathology, John A. Burns School of Medicine, University of Hawaii, USA.
  6. Department of Tropical Medicine, Medical Microbiology & Pharmacology, John A. Burns School of Medicine, University of Hawaii, USA.
  7. Department of Tropical Medicine, Medical Microbiology & Pharmacology, John A. Burns School of Medicine, University of Hawaii, USA; University of Hawaii Cancer Center, USA; Department of Pathology, John A. Burns School of Medicine, University of Hawaii, USA.

PMID: 28042618 PMCID: PMC5198841

Abstract

OBJECTIVE: HIV-Seropositive patients have higher risk of HPV infection even on anti-retroviral therapy. Infection with high-risk HPV genotypes can cause dysplasia leading to cancer. This study assessed HPV at different anatomical sites in HIV-seropositive individuals and factors associated with anal squamous intraepithelial lesions (ASIL).

METHODS: Specimens were obtained from multiple anatomical sites for each participant in conjunction with routine screening for anal dysplasia. Female specimens included cervical and anal cytologies and oral wash. Male specimens included anal cytologies, oral wash, and exfoliated cells from penile head, penile shaft, scrotum, and from uncircumcised subjects, inner foreskin. Demographic and clinical characteristics were recorded. Following DNA extraction, HIV DNA copy was assessed by qPCR; HPV was genotyped. Statistical analyses included calculation of odds ratios (OR) and 95% confidence intervals (CI), t-tests or Mann-Whitney tests.

RESULTS: Males were more likely to have ASIL: 29/50 (58%) compared to 1/11 females (9%) (OR=13.81, 95% CI: 1.64-116.32). HPV 6 or 11 in anal specimens was significantly associated with ASIL (OR= 6.29, 95% CI: 1.49-26.44). Number of HPV genotypes in anal specimens was also significant: ASIL+ (3.4 ± 3.1) versus ASIL- (1.6 ± 3.1) (p=0.009). Among 44 males, HPV was detected from at least one anatomical site for 33 participants (75%): 27 anus (61%), 19 oral wash (44%), 17 penile shaft (39%), 11 scrotum (26%), 10 penile head (23%), 0 foreskin. Detection of HPV in penile shaft specimens was significantly associated with ASIL (OR=6.79, 95% CI: 1.57-29.36) as was number of HPV genotypes in penile shaft specimens: ASIL+ (2.4 ± 4.0) versus ASIL- (0.6 ± 1.7) (p=0.025). Only 1/11 females had ASIL; only 1/11 females had cervical dysplasia: OR was not estimable due to small numbers.

CONCLUSIONS: Males were more prone to ASIL than females. HPV at anal as well as non-anal sites may be indicative of ASIL.

Keywords: Anal cancer; Anal dysplasia; HIV; HPV; Human immunodeficiency virus; Human papillomavirus

References

  1. AIDS. 2010 Jun 1;24(9):1307-13 - PubMed
  2. Sex Transm Dis. 2013 Jan;40(1):3-10 - PubMed
  3. J Natl Cancer Inst. 2015 Apr 29;107(6):djv086 - PubMed
  4. Dis Colon Rectum. 2010 Aug;53(8):1135-42 - PubMed
  5. J Neuropsychiatry Clin Neurosci. 2012 Winter;24(1):71-80 - PubMed
  6. J Clin Microbiol. 2000 Jan;38(1):357-61 - PubMed
  7. J Infect Dis. 2013 Apr 15;207(8):1235-41 - PubMed
  8. Nurs Times. 2005 Mar 1-7;101(9):38-41 - PubMed
  9. AIDS. 2005 Sep 2;19(13):1407-14 - PubMed
  10. J Infect Dis. 2005 Jul 1;192(1):46-55 - PubMed
  11. Am J Epidemiol. 2013 Sep 15;178(6):877-84 - PubMed
  12. Vaccine. 2012 Nov 20;30 Suppl 5:F24-33 - PubMed
  13. J Acquir Immune Defic Syndr. 2008 Aug 1;48(4):491-9 - PubMed
  14. J Pathol. 2008 Jan;214(2):231-41 - PubMed
  15. Cancer Cytopathol. 2011 Feb 25;119(1):5-19 - PubMed
  16. Diagn Cytopathol. 2011 May;39(5):323-7 - PubMed
  17. JAMA. 2002 Apr 24;287(16):2114-9 - PubMed
  18. AIDS. 2014 Jul 17;28(11):1696-8 - PubMed
  19. JAMA. 2002 Apr 24;287(16):2120-9 - PubMed
  20. New Microbiol. 2006 Apr;29(2):81-8 - PubMed
  21. J Dtsch Dermatol Ges. 2008 Nov;6(11):925-34 - PubMed
  22. Curr Opin Infect Dis. 2009 Apr;22(2):109-14 - PubMed
  23. J Invest Dermatol. 2008 Sep;128(9):2316-24 - PubMed
  24. J Neurovirol. 2012 Feb;18(1):69-73 - PubMed
  25. J Clin Virol. 2013 Sep;58(1):168-75 - PubMed
  26. J Infect Dis. 2010 May 1;201(9):1331-9 - PubMed
  27. PLoS One. 2014 Mar 20;9(3):e92208 - PubMed

Publication Types

Grant support